CardioSignal 63

CardioSignal 63

CardioSignal 62

CardioSignal 62

CardioSignal 61

CardioSignal 61

CardioSignal 60

CardioSignal 60

CardioSignal 59

Indication of echocardiography in pre-op assessment

CardioSignal 58

Extended anticoagulation after DVT

CardioSignal 56

Anticoagulation in paroxysmal atrial fibrillation

CardioSignal 55

Indications for DPI in CCS

CardioSignal 57

Management of Mitral Stenosis

Cardio-Signal 54

prophylactic anticoagulation in nonorthopedic surgical patients

Cardio-Signal 53

Management of aortic root dilation due to bicuspid aortic valve

Cardio-Signal 52

Infective Endocarditis prophylaxis in patients with ICD

Cardio-Signal 51

Management of antithrombotic therapy after prosthetic valve implantation

Cardio-Signal 50

Management of Rheumatic Mitral Stenosis

Cardio-Signal 49

Extended oral anticoagulation after pulmonary embolism

Cardio-Signal 48

Management of Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Cardio-Signal 47

Management of hypertriglyceridemia

Cardio-Signal 46

Management of Mitral Stenosis

Cardio-Signal 45

DPI in high risk post-MI patients

Cardio-Signal 44

Screening for asymptomatic carotid stenosis

Cardio-Signal 43

Management of Mitral valve regurgitation

Cardio-Signal 42

Extended anticiagulation after DVT

Cardio-Signal 41

Antithrombotic management prior to dental procedures

Cardio-Signal 40

Antithrombotic therapy for valve prostheses

Cardio-Signal 39

Statins for the primary prevention of ASCVD

Cardio-Signal 38

Secondary prophylaxis of rheumatic heart disease

Cardio-Signal 37

Antithrombotic therapy in valve prostheses

Cardio-Signal 36

management of Tricuspid regurgitation

Cardio-Signal 35

Apixaban dose adjustment

Cardio-Signal 34

Antithrombotic therapy for valve prostheses

Cardio-Signal 33

Management of aortic regurgitation

Cardio-Signal 32

Interpretation of exercise stress test

Cardio-Signal 31

Cardio-Signal 30

Pre-operative management of NOACs

Cardio-Signal 29

SGLT2 inhibitors in HFrEF

Cardio-Signal 28

Long-term follow-up of coarctation of aorta

Cardio-Signal 27

Aortic Coarctation follow-up

Cardio-Signal 26

ICD implantation in HCM

Cardio-Signal 25

NOACs in valvular AF

Cardio-Signal 24

Administration of Ivabradine in HFrEF

Cardio-Signal 23

ICD implantation in HCM

Cardio-Signal 22

Anticoagulation in transient AF

Cardio-Signal 21

changing between P2Y12 inhibitors

Cardio-Signal 20

DPI in AF

Cardio-Signal 19

Changing between P2Y12 inhibitors

Cardio-Signal 18

Anticoagulation in superficial venous thromboembolism

Cardio-Signal 17

Mitral Regurgitation follow-up

Cardio-Signal 16

Extended anticoagulation in PTE

Cardio-Signal 15

Thromboprophylaxis in COVID-19

Cardio-Signal 14

ASCVD risk assessment

Cardio-Signal 13

N-acetyl-L-cysteine for the prevention of contrast nephropathy

Cardio-Signal 12

Apixaban dose adjustment

Cardio-Signal 11

Management of dyslipidemia in CCS

Cardio-Signal 10

EVAR follow-up

Cardio-Signal 9

Screening for abdominal aortic aneurysm

Cardio-Signal 8

Screening for peripheral arterial disease

Cardio-Signal 7

pre-operative management of SGLT2 inhibitors

Cardio-Signal 6

concurrent administration of ASA and Ticagrelor

Cardio-Signal 5

prescribing NOACs in AF

Cardio-Signal 4

Iron deficiency anemia in HFrEF

Cardio-Signal 3

pre-operative cardiac risk evaluation

Cardio-Signal 2

Management of asymptomatic thoracic aortic aneurysm

Cardio-Signal 1

Antibiotic prophylaxis for infective endocarditis

Guideline Directed Medical Therapy in Patients with HF

Quick review on place of MRAs in patients with HFrEF

Guideline Directed Medical Therapy in Patients with HF

Quick review on place of Beta-Blockers in patients with HFrEF

Guideline Directed Medical Therapy in Patients with HF

Updates on ACEI/ARB place in patients with HFrEF (2021 Guideline)

New FDA approved indication for Ticagrelor

Ticagrelor approved for recurrent stroke prevention

Treatment goals for LDL cholesterol across categories of total CV risk

Overview of 2019 ESC/EAS Guidelines for the management of dyslipidemia

Monitor eGFR in Patients Treated with Metformin

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Patient factors influencing the selection of glucose-lowering drugs other than SGLT2i and metformin in T2D and CKD

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Glycemic Management for patients with T2DM and CKD

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

Monitoring of ACEI/ ARB Treatment in Patients with T2DM and CKD

KDIGO 2020 Clinical Practice Guideline for DM Management in CKD

A music from the heart

The S3 sound mixed into a delightful eastern melody by a talented Iranian physician

Dosage Modification of DOACs in Different Clinical Scenarios & in Renal Impairment

Algorithmic approach to DOACs Dose Adjustment in CKD

Cardiovascular medication interactions with antiviral agents used for COVID-19

Quick review of CV medications interactions with medications used for COVID-19

Cardiovascular medication interactions with antiviral agents used for COVID-19: Second Update

Quick review of CV medications interactions with medications used for COVID-19

AF Patients on NOACs Undergoing Elective PCI or Angiography: When to Hold?

Pre-procedural management of DOACs